Phase 2 Serous Carcinoma Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Uterine CancerUterine Serous CarcinomaUterine Carcinoma
Joyce Liu, MD25 enrolled2 locationsNCT06369155
Recruiting
Phase 1Phase 2
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Triple-Negative Breast CancerAdvanced Solid TumorHead and Neck Squamous Cell Carcinoma+7 more
Volastra Therapeutics, Inc.200 enrolled14 locationsNCT05902988
Recruiting
Phase 2
A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
HER2/Neu+ Uterine Serous Carcinoma
Yale University50 enrolled3 locationsNCT02491099
Recruiting
Phase 2
Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer
Ovarian CancerFallopian Tube CancerOvary Cancer+4 more
University College, London80 enrolled1 locationNCT05080556
Recruiting
Phase 2
Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma
Endometrial CarcinomaSerous Carcinoma
Shandong University83 enrolled1 locationNCT04716686
Completed
Phase 2
Uterine Serous Papillary Cancer (UPSC) Trial
Uterine Papillary Serous Carcinoma
Queensland Centre for Gynaecological Cancer30 enrolled1 locationACTRN12607000125426